1/10/2024 0 Comments Sononym for freeThere are far fewer demo-scale (15%) and commercial-scale (16%) facilities: “The majority of users are looking for commercial-scale or demo-scale facilities that simply don’t exist to meet current, let alone future, demand,” it reads.Īs for regional availability: “There is less capacity in APAC that has been uploaded but we expect this figure to grow as biomanufacturing becomes more mature and more CDMOs (contract development and manufacturing organizations) such as ADM’s ScaleUp Bio are established in the region.”ĭata on Asian capacity is “harder to discern,” says Synonym Bio. ![]() Most available facilities are bench scale (29%) or pilot scale (41%), with providers ranging from contract manufacturing organizations and academic research facilities to well-known players such as Corbion and Phyton Biotech to new players such as nth Bio and Motif Foodworks, According to the Capacitor data. “But achieving commercial adoption requires a network of large-scale infrastructure, which as shown in the Capacitor data, does not yet exist,” reads the report.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |